Combination immunotherapy is producing response rates ranging from 26 to 38% among patients with metastatic bladder cancer in a clinical trial led by MD Anderson Cancer Center.
“Until the first, recent approval of immune checkpoint therapy, patients with bladder cancer have not had new treatment options for over 30 years. We’re quickly moving from immune checkpoint monotherapy to immune checkpoint combination therapies to improve...
The largest analysis of metastatic melanoma patients who received a targeted therapy combination shows the treatment provides long-term survival...
A new trial underway at MD Anderson may lead to new therapies for triple negative breast cancer.
Fifteen to 20% of breast cancers...
Patients who’ve been successfully treated for breast, colon and other cancers can go on to develop an often-fatal form of leukemia, sometimes years after completion of treatment, due to a genetic mutation leading to secondary malignancies known as therapy-related myeloid neoplasms (t-MNs).
A study conducted by researchers at MD Anderson Cancer Center revealed pre-leukemic mutations, called clonal hematopoiesis, may predict...
When female employees of a mystery shopping firm called posing as 17-year-olds interested in tanning, 81% of indoor tanning facilities complied...
The University of Texas Health Science Center at San Antonio and The University of Texas MD Anderson Cancer Center are announcing...
Three years ago, Stephen Cadmus faced a dilemma. He needed to see a doctor, but he had no health insurance.
To get the medical...
Chemistry professor Bindu Chakravarty rarely missed a day teaching at Houston Community College. So when she called in sick one morning, it...
The first clinical study of a new drug designed to kill cancer cells by depriving them of the nutrients they need to survive is underway at...
Jan Barbo likely got hepatitis C from a blood transfusion. Almost 50 years ago, she suffered an ectopic pregnancy when a fertilized egg attached...
The most common malignant brain tumors in children, medulloblastomas, are usually incurable if they recur. Even with surgery, chemotherapy...
Two drugs used together — ribociclib and letrozole, improve progression-free survival of post-menopausal women diagnosed with hormone receptor-positive...
The American Lung Association and MD Anderson Cancer Center have announced a new partnership aimed at increasing coverage and access...
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, a new MD Anderson...
Researchers at MD Anderson have discovered a potentially new therapeutic approach for certain brain cancers in which the enzyme enolase (ENO1...
A genome-wide association study has tied common genetic variants to pre-treatment pain, a finding with potential implications for precision...
A study in mice combining two inhibitor drugs for treatment of chronic myeloid leukemia (CML) has revealed potential for stopping the disease...
Cervical cancer is the fourth most common cancer among women worldwide and was responsible for approximately 266,000 deaths in 2012, according...
Mastectomy plus reconstruction for patients with early-stage breast cancer is significantly riskier and costlier than other less-invasive...
In a pilot study of 13 newly diagnosed, BRCA-positive breast cancer patients at MD Anderson, all had their tumors shrink significantly when...
“Loss of interferon-gamma signaling caused by these mutations is the first clearly defined resistance pathway to ipilimumab found in tumor...
Hereditary cancers are caused by genetic mutations passed down from parents to children. The National Cancer Institute estimates...
The human papillomavirus (HPV) is known to cause a variety of cancers, but screening guidelines and a reliable early-detection test exist...
According to a recent report from the Centers for Disease Control and Prevention (CDC), adolescent vaccination rates for the human...
A program designed to reduce cervical- and breast-cancer deaths among women in developing countries is celebrating its fifth anniversary this...
When Allison Easley awoke one morning with soreness under her right armpit, she thought she’d pulled a muscle. But the pain soon became worse...
A study that indicates how advanced melanoma responds to an immunotherapy, published in Cancer Discovery, demonstrates a revolutionary...
MD Anderson Cancer Center has been awarded $19.1 million in research grants in the most recent round of funding from the Cancer...
Two cellular pathways have been shown to play a role in regulating the immune-system protein PDL1, a finding that could lead to increased...
As with most cancers, triple-negative breast cancer (TNBC) cells have abnormal amounts of chromosomes or DNA copy number aberrations (CNAs...
MD Anderson again has been ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” rankings. Since the rankings...
Chemotherapy, radiation, hormone therapy, various cancer drugs and even cancer itself can weaken patients’ bones, leading to cancer-related...
Up to 15% of colorectal cancers show a genetic mutation known as DNA mismatch repair deficiency, or dMMR. Until now, little has been known...
Reported online in the July 28 issue of Molecular Cell, a study conducted at MD Anderson has shown that a protein called ZMYND8 blocks expression...
Patients diagnosed with blood-related cancers such as leukemia, lymphoma and multiple myeloma often undergo what is called a hematopoietic...
Tobacco use has significantly declined during the past five decades since the release of the U.S. Surgeon General’s Report on Smoking &...
Researchers with MD Anderson’s Colorectal Cancer Moon Shot are sharpening the focus of a genetic tool designed to classify colorectal cancer...
In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic...
Early-stage breast cancer patients receiving a shorter course of whole-breast radiation with higher radiation doses reported equivalent cosmetic...
Proton therapy can deliver a higher radiation dose to lung tumors and a lower dose to healthy tissue compared to standard radiation therapy...
Using an innovative approach to identify a cancer’s genetic vulnerabilities by more swiftly analyzing human tumors transplanted into mice,...
This summer, many preschoolers across Texas are safely enjoying their vacation time outdoors thanks to Ray and the Sunbeatables™, a sun-safety...
A mitogen-activated protein kinase (MAP) known as p38 appears to show promise for halting breast cancer metastasis, and may point to the potential...
Separate immunotherapies work well together, pumping up the impact of immune system attack on tumors, an unprecedented clinical trial shows...
Advances that could change gynecologic cancer standard–of-care treatments are the centerpiece of key studies were presented by researchers...
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new...
It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular...
When Gene Duncan visited his family doctor for a respiratory infection, little did he realize he’d be diagnosed with bronchitis — and something...
An MD Anderson study is seeking new drugs to combat triple-negative breast cancer, an aggressive form of the disease that doesn’t rely on...
The immune checkpoint blockade drug nivolumab reduced tumor burden in 24.4 percent of patients with metastatic bladder cancer, regardless...
Lung cancer patients whose cancer has spread to three or fewer sites may benefit from aggressive surgery or radiation after completing standard...
Patients in a first-of-its-kind clinical trial will receive a vastly expanded dose of their own T cells — white blood cells that are the specialized...
The 90 percent of cancer patients who experience pain due to nerve damage caused by tumors, surgery, chemotherapy or radiation may someday...
Receptors for leptin, a protein hormone, may be associated with tumor recurrence in patients with renal cell carcinoma (RCC), providing further...
Eight of MD Anderson Cancer Center's top young researchers have been named Andrew Sabin Family Fellows and will receive $100,000 over two...
Researchers at MD Anderson Cancer Center have announced a new method for detecting DNA mutations in a single cancer cell versus current technology...
The Affordable Care Act (ACA) was signed into law in 2010 to improve access to affordable health coverage for Americans, and a major focus...
The drug LOXO-101 appears to significantly reduce tumors in patients with varied types of genetically defined cancer, according to a new MD...
MD Anderson Cancer Center fully supports new rules recently issued by the Food and Drug Administration (FDA) to extend federal regulatory...
Long associated with liver cancer and non-Hodgkin’s lymphoma, the hepatitis C virus (HCV) for the first time has been associated with certain...
Researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab on...
A long non-coding RNA (lncRNA) called NBR2, once considered to be a “junk” gene, may very well play a significant role in tumor development...
Consuming a diet with a high glycemic index, a classification of how rapidly carbohydrates elevate blood sugar levels, was independently associated...
Using the latest advances in endoscopic resection techniques, more than 75 percent of patients with complex colon polyps could avoid surgery...
A new clinic to identify and monitor those at high risk for developing pancreatic cancer continues to expand after opening last year....
Two cancer experts at The University of Texas MD Anderson Cancer Center have been named to a blue ribbon panel to advise the National Cancer...
A new breast cancer staging system developed by researchers at MD Anderson Cancer Center finds that incorporating tumor biology is a critical...
Cancer survivors are more likely to die from heart disease than cancer; therefore, patients must be closely monitored for heart problems during...
Cancer immunotherapy leaders at MD Anderson Cancer Center will work with experts at five other cancer centers in a new alliance funded by...
MD Anderson researchers are proposing a new model to allow doctors to predict outcomes more accurately for patients with oropharyngeal (middle...
New findings about where and how aggressive forms of prostate cancer potentially begin may lead to new therapies for hard-to-treat and lethal...
ONC201, an anti-cancer drug that triggers cell death in various tumor types, may be effective in treating some blood cancers, including mantle...
Looking at data from a standard technology in a novel way, MD Anderson researchers have discovered that certain genetic aberrations are two...
The nation’s premier cancer research group, oncology society and 20 other organizations recently released a statement calling for state and...
In response to low national vaccination rates for the human papillomavirus (HPV), The University of Texas MD Anderson Cancer Center has joined...
An international study has revealed new information about diffuse glioma, the most common type of tumor found in some 80% of adult brain cancer...
Is the best way to treat an early precursor to breast cancer no treatment at all? That’s what MD Anderson researchers and allied institutions...
A new procedure developed by MD Anderson surgeons is helping doctors determine which lymph nodes in breast cancer patients are cancerous and...
After extensive internal and external peer review, MD Anderson expanded its Moon Shots Program by adding six new moon shots to its focused...
Loretta Preston kicked her cigarette addiction two years ago.
“Quitting wasn’t easy,” she says. “I’d smoked for 40 years.” Then, the...
Feb. 4 is World Cancer Day, which was organized by the Union for International Cancer Control to raise awareness of the actions needed to...
In cancer, cell signaling pathways are the critical chain of events that can either quash or quicken disease progression.
A multi-institutional...
The 140,000 U.S. women diagnosed each year with early-stage breast cancer, when the tumor is still small and hasn’t spread, have a variety...
Researchers at MD Anderson have found that pancreatic cancer tumors essentially spill their molecular secrets when they shed their complete...
Breast cancer patients who delay chemotherapy more than 90 days after surgery are one-third more likely to die within five years, compared...
Depression significantly impacts five-year survival and recurrence in head and neck cancer patients, according to a new MD Anderson study....
Immune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer...
High amounts of dietary sugar increased the risk that mice would develop breast cancer, and that it would spread to their lungs, MD Anderson...
The majority of women diagnosed with ovarian cancer face a difficult journey of repeated treatments that include aggressive surgeries and...